Results 141 to 150 of about 41,151 (199)

L-Dopa-induced changes in aperiodic bursts dynamics relate to individual clinical improvement in Parkinson's disease. [PDF]

NPJ Parkinsons Dis
Agouram H, Neri M, Angiolelli M, Depannemaecker D, Bahuguna J, Schwey A, Régis J, Carron R, Malfait N, Eusebio A, Daucé E, Sorrentino P.   +11 more
europepmc   +1 more source

"Panic attacks" in Parkinson's disease. A long-term complication of levodopa therapy.

, 1993
A. Vázquez, F J Jiménez-Jiménez, Pedro Ruiz, D García-Urra   +3 more
openalex  

Combined molecular characterization and dopa-responsive treatment in two patients with NR4A2-associated intellectual developmental disorder. [PDF]

Front Genet
Liang N, Li T, Deng Y.
europepmc   +1 more source

Disease-Modifying Trials in Treated Parkinson's Disease: "Stable Treated" Does Not Equate with Biological Stability. [PDF]

Mov Disord
Mouradian MM, Stoessl AJ, Lang AE.
europepmc   +1 more source

The Identification and Challenges of Dopamine Dysregulation Syndrome: A Case Report. [PDF]

Cureus
Sulaiman A, Leppla I.
europepmc   +1 more source

Quantitative analysis of gait parameters in Parkinson's disease and the clinical significance. [PDF]

Front Neurol
Yin W, Gao H, Liang B, Liu R, Liu Y, Shen C, Niu X, Wang C.   +7 more
europepmc   +1 more source

Levodopa Intestinal Gel Infusion Therapies in Advanced Parkinson's Disease: A Swedish Study on Real-World Use and Costs. [PDF]

Neurol Ther
Odin P, Tærud C, Samuelsson J, Sabelström E, Lagerlund J, Freilich J, Stelmaszuk MN.   +6 more
europepmc   +1 more source

New Onset Medically Refractory Seizures in an Adult With Parkinson's Disease and Vitamin B6 Deficiency Case Report. [PDF]

Neurohospitalist
Nathan CL, Ghandour D, May J, Bega D, Schuele S.   +4 more
europepmc   +1 more source

Effect of adding selegiline to levodopa in early, mild Parkinson's disease. Formal systematic review of data on patients in all relevant trials is required.

, 1998
Carl Counsell
openalex